Epigenomics AG (EPGNF)
2.50
0.00 (0.00%)
USD |
OTCM |
May 17, 16:00
Epigenomics Gross Profit Margin (Quarterly): 92.86% for June 30, 2023
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2023 | 92.86% |
| March 31, 2023 | 71.64% |
| December 31, 2022 | 73.74% |
| September 30, 2022 | 75.17% |
| June 30, 2022 | 75.40% |
| March 31, 2022 | 77.39% |
| December 31, 2021 | 75.69% |
| September 30, 2021 | 99.24% |
| June 30, 2021 | 77.78% |
| March 31, 2021 | 78.30% |
| December 31, 2020 | 89.70% |
| September 30, 2020 | 80.37% |
| June 30, 2020 | 81.93% |
| March 31, 2020 | 76.15% |
| December 31, 2019 | 82.37% |
| September 30, 2019 | 76.79% |
| June 30, 2019 | 79.31% |
| March 31, 2019 | 71.90% |
| December 31, 2018 | 30.28% |
| September 30, 2018 | 76.47% |
| June 30, 2018 | 72.94% |
| March 31, 2018 | 88.67% |
| December 31, 2017 | 94.34% |
| September 30, 2017 | 78.90% |
| June 30, 2017 | 65.04% |
| Date | Value |
|---|---|
| March 31, 2017 | 89.32% |
| December 31, 2016 | 90.57% |
| September 30, 2016 | 30.67% |
| June 30, 2016 | 33.81% |
| March 31, 2016 | 89.15% |
| December 31, 2015 | 35.09% |
| September 30, 2015 | 34.61% |
| June 30, 2015 | 49.28% |
| March 31, 2015 | 64.85% |
| December 31, 2014 | 35.19% |
| September 30, 2014 | 65.14% |
| June 30, 2014 | 58.52% |
| March 31, 2014 | 51.60% |
| December 31, 2013 | 73.68% |
| September 30, 2013 | 63.88% |
| June 30, 2013 | 66.18% |
| March 31, 2013 | 68.73% |
| December 31, 2012 | 61.85% |
| September 30, 2012 | 70.96% |
| June 30, 2012 | 83.97% |
| March 31, 2012 | 79.84% |
| December 31, 2011 | 71.28% |
| September 30, 2011 | 79.38% |
| June 30, 2011 | 72.53% |
| March 31, 2011 | 76.01% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
71.64%
Minimum
Mar 2023
99.24%
Maximum
Sep 2021
80.22%
Average
77.78%
Median
Jun 2021
Gross Profit Margin (Quarterly) Benchmarks
| Affimed NV | -- |
| InflaRx NV | -511.9% |
| MorphoSys AG | 75.20% |
| BioNTech SE | 68.50% |
| Immatics NV | -- |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | -174.3% |
| Return on Assets | -115.8% |
| Return on Invested Capital | -174.3% |
| Profit Margin (Quarterly) | -3.76K% |
| Operating Margin (Quarterly) | -3.96K% |
| Return on Net Operating Assets | -323.9% |